DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 164 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $153,000 | -33.8% | 10,848 | -79.1% | 0.00% | – |
| Q4 2020 | $231,000 | +23.5% | 51,848 | +19.7% | 0.00% | – |
| Q3 2020 | $187,000 | -64.7% | 43,308 | -27.5% | 0.00% | -100.0% |
| Q2 2020 | $530,000 | +430.0% | 59,708 | +137.2% | 0.00% | – |
| Q2 2019 | $100,000 | -56.9% | 25,177 | -20.8% | 0.00% | – |
| Q1 2019 | $232,000 | -12.1% | 31,803 | +10.1% | 0.00% | – |
| Q4 2018 | $264,000 | -36.5% | 28,882 | -13.9% | 0.00% | -100.0% |
| Q3 2018 | $416,000 | -20.8% | 33,562 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $525,000 | +109.2% | 34,435 | +195.0% | 0.00% | 0.0% |
| Q3 2017 | $251,000 | +512.2% | 11,673 | +11.4% | 0.00% | – |
| Q4 2016 | $41,000 | -63.7% | 10,482 | -3.1% | 0.00% | – |
| Q3 2016 | $113,000 | -81.1% | 10,812 | -55.7% | 0.00% | -100.0% |
| Q3 2015 | $598,000 | +8.9% | 24,380 | +4.0% | 0.00% | 0.0% |
| Q2 2015 | $549,000 | -1.4% | 23,437 | -5.6% | 0.00% | 0.0% |
| Q1 2015 | $557,000 | – | 24,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |